Loading...
NPI 1235343187 · Metairie, LA · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Brandon Davis is a ophthalmology physician provider located in Metairie, Louisiana. This profile covers 17 Medicare and 10 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Brandon Davis |
| Address | 4224 Houma Blvd Ste 430 |
| City | Metairie |
| State | LA |
| ZIP | 70006 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | May 10, 2007 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.1M |
| Medicaid | $123.4K |
Medicare dominates this provider's payer mix in scale: total Medicare revenue is $1.1M compared with $123.4K in Medicaid, indicating Medicare is the primary source of fee–for–service income for this NPI. The NPI has been enumerated since 2007-05-10 (~19 years ago), supporting a long-standing presence in the market that likely underpins the higher Medicare volume.
Revenue concentration is high on both payers: the top three Medicare codes (J0178, J2777, J3590) account for 71.8% of Medicare revenue, while the top three Medicaid codes (92014, 92250, 92134) account for 92.3% of Medicaid revenue. This level of concentration signals that changes in utilization or reimbursement for a small set of services would materially affect overall revenue.
The Medicare code mix indicates a retina-focused medical practice with a procedural emphasis: J0178 and J2777 (aflibercept and faricimab injections) and J3590 (unclassified biologics) together drive the bulk of Medicare dollars, reflecting frequent intravitreal biologic therapy. Complementary Medicare codes such as 67028 (vitreous injections) and angiography/imaging codes (92235, 92240, 92134) further support an interventional retina and diagnostic imaging service line.
Despite biologics driving Medicare dollars, competitive standing for those injectables is modest: J0178 ranks in the 40th percentile nationally, J2777 in the 46th percentile, and J3590 in the 47th percentile, each labeled in the source as "typical, unremarkable volume for this code." In contrast, the provider is notably above typical national volume for established comprehensive visits under 92014 on Medicare (96th percentile), indicating a heavier-than-average clinic visit load relative to peers.
On Medicaid the practice shows a different operational footprint: 92014 (established comprehensive eye exam) is the largest Medicaid revenue source at $69.7K (56.4% of Medicaid revenue) and 92250 (fundus photography) contributes $31.6K (25.6%). Those two codes together suggest that Medicaid activity is concentrated in outpatient exams and retinal imaging rather than high-dollar biologic injections. 92250 ranks at the 76th in-state percentile (described as typical, unremarkable volume), indicating a relatively strong in-state position for fundus photography.
Imaging and diagnostic procedures are prominent across both payers: Medicare entries for 92134 and 92235 rank in the 93rd and 91st percentiles respectively (both characterized in the source as "typical, unremarkable volume" despite high rank), and Medicaid shows substantial volume to 92134 as well. This pattern—high clinic exam volume plus robust imaging—aligns with a practice that pairs diagnostic retinal imaging with treatment visits.
There are pockets of low national standing within the provider's Medicare mix: codes such as J3490 appear in the top-25 list but rank at the 3rd percentile nationally (labeled typical, unremarkable in the source), indicating minimal relative activity on some unclassified drug line items. These low-percentile entries suggest most high-dollar pharmaceutical billing is concentrated in the specific biologics (J0178, J2777, J3590) rather than a broad array of drug codes.
From a payer-strategy viewpoint, Medicaid exposure is limited in absolute dollars ($123.4K) but highly concentrated (92.3% from three codes), so contracting or utilization-management changes in outpatient exam or photography reimbursement could disproportionately affect Medicaid revenue for this provider. Conversely, Medicare risk is concentrated around intravitreal biologics (71.8% from three codes) but competitive standing for those biologics is around the median nationally, so market share gains or losses would likely come from adjustments to injection volume or referral patterns rather than broad market dominance.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 510 | $690 | $350.9K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 8,820 | $30 | $255.8K |
| J3590 | Unclassified biologics | 80 | $2,120 | $165.2K |
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 1,080 | $90 | $94.2K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 570 | $80 | $46.7K |
| J3490 | Unclassified drugs | 20 | $1,990 | $31.8K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,130 | $30 | $31.7K |
| 92235 | The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken… | 300 | $90 | $26.7K |
| 67210 | The provider destroys a lesion of the retina using a laser beam that heats up the tissue. | 50 | $390 | $17.9K |
| 92201 | The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece… | 760 | $20 | $14.4K |
Showing 1–10 of 17
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
17 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 17 | 50 | 300 | $680 | $371.5K |
| J2777 | 12 | 30 | 6,660 | $30 | $309.4K |
| J3590 | 2 | 10 | 70 | $490 | $92K |
| J3490 | 16 | 20 | 50 | $620 | $49.1K |
| 67028 | 22 | 70 | 410 | $80 | $44.3K |
| 92240 | 2 | 10 | 230 | $130 | $29.9K |
| 92014 | 29 | 470 | 170 | $80 | $23.9K |
| 67210 | 4 | 10 | 40 | $380 | $16.5K |
| 92012 | 281 | 350 | 100 | $60 | $11.7K |
| 92235 | 7 | 40 | 70 | $90 | $11.3K |
Showing 1–10 of 17
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 1,160 | $60 | $69.7K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 880 | $40 | $31.6K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 670 | $20 | $12.7K |
| 92226 | N/A | 600 | $20 | $9K |
| 92225 | N/A | 20 | $20 | $410 |
| 92202 | The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece… | 30 | $10 | $180 |
| 1036F | N/A | 100 | $0 | $0 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 20 | $0 | $0 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 190 | $0 | $0 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 100 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
10 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 92014 | An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group… | 310 | 660 | 1,070 | $60 | $129.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 59 | 130 | 490 | $10 | $19.4K |
| 92250 | Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,… | 52 | 210 | 200 | $20 | $17.5K |
| 92226 | N/A | 13 | 30 | 450 | $10 | $5.5K |
| 92225 | N/A | 18 | 20 | 60 | $10 | $2.3K |
| 92202 | The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece… | 22 | 20 | 110 | $1 | $1.3K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 163 | 250 | 420 | $1 | $50 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 115 | 120 | 270 | $1 | $1 |
| 1036F | N/A | 299 | 380 | 570 | $1 | $1 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 45 | 80 | 190 | $0 | $0 |
Other providers in the same ZIP code as Brandon Davis, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.